The University of Texas MD Anderson Cancer Center
Ibrahim Sahin , Hesham Hassabo , Yehua Shen , Bryan Kee , Manal Hassan , Chris Garrett
Background: We previously reported improved overall survival (OS) associated with metformin usage in a retrospective study of type 2 diabetes mellitus (DM) patients with colorectal (CRC) (Br J Cancer 2012;106:1374-8). We sought to determine whether this effect could be validated in an independent data set. Methods: Under an IRB-approved protocol, 6,128 patients with CRC based on ICD-9 billing codes diagnosed between 1995-2005 were reviewed; of these 683 were determined to have type 2 DM. Results: Of the 683 diabetic CRC patients, 407 (59.5%) were male. The patient’s stage at diagnosis was: stage I (67, 9.8%), II (162, 23.7%), III (247, 36.1%), IV (166, 24.3%) and unknown stage (41, 6%). The number of patients using metformin at the time of first evaluation was 146 (21.3%). A significantly better median OS was observed in CRC patients with metformin use in both all-stage and stage III groups (p = 0.017, p = 0.029 respectively); median OS results demonstrated in table below. Conclusions: This independent retrospective data set validated the OS benefit associated with metformin use previously reported in patients with type 2 DM and CRC. Future prospective studies will be required to confirm the benefit of metformin in this clinical setting.
Median OS (months) |
95% Confidence intervals |
P value | |
---|---|---|---|
Metformin (all stages) | 60.1 | 48.3-71.9 | 0.017 |
Non-metformin (all stages) | 48.1 | 41.7-54.8 | |
Metformin (stage III colon and rectum) | 94.9 | 73.8-116.1 | 0.029 |
Non-metformin (Stage III colon and rectum) | 67.5 | 54.5-80.4 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2015 ASCO Annual Meeting
First Author: Amal Al Omari
2014 ASCO Annual Meeting
First Author: Jessica K Paulus
2014 ASCO Annual Meeting
First Author: Abdulrahman Ali Alshehri
2022 ASCO Annual Meeting
First Author: Christian Stephens